Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$275.42
-1.0%
$326.24
$261.59
$473.50
$7.85B0.87203,243 shs164,771 shs
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$103.81
+0.3%
$109.54
$77.56
$116.04
$25.25B0.682.27 million shs1.64 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$13.33
-2.9%
$15.17
$12.85
$30.41
$2.32B0.944.76 million shs6.84 million shs
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$177.07
$177.00
$103.67
$177.38
$16.26B1.06746,779 shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-2.65%-4.38%-18.49%-12.14%-36.41%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.16%-2.80%-6.78%-2.06%+28.01%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-0.07%+4.57%-8.92%-32.54%-48.17%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6019 of 5 stars
3.43.00.04.21.83.31.9
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.362 of 5 stars
1.34.03.33.61.91.73.1
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.2895 of 5 stars
4.21.00.00.03.02.51.3
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0069.92% Upside
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-0.71% Downside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.46
Hold$22.2366.77% Upside
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/A

Current Analyst Ratings

Latest TDOC, VAR, BIO, and CAH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/5/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
3/6/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $17.00
2/29/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$22.00
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$125.00
2/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$17.00
2/21/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$22.00 ➝ $18.00
2/21/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $19.00
2/21/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$26.00 ➝ $25.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B2.94$11.69 per share23.57$306.51 per share0.90
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.72 per share11.90($11.20) per share-9.27
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.87$0.79 per share16.93$14.05 per share0.95
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$3.17B5.13$5.07 per share34.94$22.92 per share7.73

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.03N/A-23.86%3.90%2.77%5/7/2024 (Confirmed)
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5440.8713.041.000.30%-57.44%3.89%5/2/2024 (Confirmed)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.34N/AN/AN/A-8.47%-9.22%-4.89%5/23/2024 (Estimated)
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
$269.20M$3.9160.4330.11N/A8.50%18.45%8.08%N/A

Latest TDOC, VAR, BIO, and CAH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.04N/A-$2.04N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
4/25/2024N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02N/A$637.31 million$646.13 million    
2/20/2024Q4 2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.22-$0.17+$0.05-$0.17$670.79 million$660.50 million      
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.93%+1.00%78.74%27 Years
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/AN/AN/AN/AN/A

Latest TDOC, VAR, BIO, and CAH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.66
3.54
3.47
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
N/A
1.40
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
86.96%

Insider Ownership

CompanyInsider Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.06%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
1.63%
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
0.78%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.65 millionOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.31 million166.55 millionOptionable
Varian Medical Systems, Inc. stock logo
VAR
Varian Medical Systems
10,00091.84 millionN/AOptionable

TDOC, VAR, BIO, and CAH Headlines

SourceHeadline
Varian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon TechnologyVarian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon Technology
prnewswire.co.uk - April 25 at 5:58 PM
The effect of using a large language model to respond to patient messagesThe effect of using a large language model to respond to patient messages
thelancet.com - April 24 at 10:26 PM
CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024CQ Medical™ (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024
prnewswire.co.uk - April 24 at 12:26 PM
Healthway Cancer Care Hospital offers world-class cancer care at affordable pricesHealthway Cancer Care Hospital offers world-class cancer care at affordable prices
businessmirror.com.ph - April 24 at 12:26 PM
Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”Q&A: Dr. Griffin Davis, Holy Cross Health’s chief clinical officer, on restructuring to offer “a better, different way of delivering care”
bizjournals.com - April 22 at 1:59 PM
DelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightDelveInsight Business Research, LLP: Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finanznachrichten.de - April 18 at 6:35 PM
This device treats overactive bladder without drugs or surgeryThis device treats overactive bladder without drugs or surgery
medicaldesignandoutsourcing.com - April 18 at 6:35 PM
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsightGlobal Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
finance.yahoo.com - April 18 at 6:35 PM
Raigmore Hospital in Scotland selects RayCareRaigmore Hospital in Scotland selects RayCare
finance.yahoo.com - April 17 at 3:14 PM
PH’s 1st dedicated cancer hospital rises in Taguig CityPH’s 1st dedicated cancer hospital rises in Taguig City
msn.com - April 15 at 10:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets™
finance.yahoo.com - April 15 at 5:35 PM
Robotic Radiotherapy Market Worth $1.9 billion | MarketsandMarketsRobotic Radiotherapy Market Worth $1.9 billion | MarketsandMarkets
finanznachrichten.de - April 15 at 12:34 PM
Ayala cancer hospital ready to serve 10,000 patients this yearAyala cancer hospital ready to serve 10,000 patients this year
msn.com - April 11 at 2:56 PM
Global Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMIGlobal Superficial Radiation Therapy System Industry is expected to reach US$ 58.2 Million by 2030, With A strong 3.8% CAGR | FMI | FMI
fmiblog.com - April 8 at 6:11 PM
Next-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancerNext-generation PARP inhibitor demonstrates clinical benefit in patients with homologous recombination repair-deficient breast cancer
eurekalert.org - April 8 at 1:10 PM
The Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggestsThe Lancet: Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggests
eurekalert.org - April 5 at 1:10 AM
Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032Global Brachytherapy Market Set to Skyrocket, Surpassing US$ 2.1 Billion by 2032
fmiblog.com - April 4 at 1:43 AM
New method allows miniature robots and surgical instruments to achieve precise localization inside the bodyNew method allows miniature robots and surgical instruments to achieve precise localization inside the body
msn.com - April 2 at 3:39 PM
Global Radiotherapy Device Industry Expects to Reach US$ 12,895.19 Million with 6.6% CAGR by 2033 | FMI studyGlobal Radiotherapy Device Industry Expects to Reach US$ 12,895.19 Million with 6.6% CAGR by 2033 | FMI study
fmiblog.com - April 2 at 3:39 PM
Baxter International lands key FDA clearance for infusion pumpBaxter International lands key FDA clearance for infusion pump
chicagobusiness.com - April 1 at 4:57 PM
Govt Confirms Outbreak of Infectious Disease Amid Covid-19 Fears; Gives Prevention TipsGovt Confirms Outbreak of Infectious Disease Amid Covid-19 Fears; Gives Prevention Tips
msn.com - March 28 at 8:17 PM
Robots in Healthcare Market Future Looks Bright for Market Size with Soaring ProjectionsRobots in Healthcare Market Future Looks Bright for Market Size with Soaring Projections
taiwannews.com.tw - March 28 at 8:44 AM
Radiotherapy Market Will Increase USD 32.6 Billion By 2033 And Has Guessed Around 5.9% CAGRRadiotherapy Market Will Increase USD 32.6 Billion By 2033 And Has Guessed Around 5.9% CAGR
pharmiweb.com - March 25 at 8:52 AM
Kahlert Foundation donates $2.5M to Carroll Hospital for advanced cancer-fighting technologyKahlert Foundation donates $2.5M to Carroll Hospital for advanced cancer-fighting technology
thedailyrecord.com - March 20 at 1:36 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Varian Medical Systems logo

Varian Medical Systems

NYSE:VAR
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.